Compare Humana Inc (HUM) vs Thomson Reuters Corp (TRI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Thomson Reuters Corp — how do they compare? Humana Inc trades at $431.03 (market cap $46.49B), while Thomson Reuters Corp trades at $103.21 (market cap $43.89B). The key difference: Humana Inc and Thomson Reuters Corp are close in size by market cap, and Thomson Reuters Corp pays the higher dividend (2.58%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 51 Days and Thomson Reuters Corp for 63 Days on average.
| HUM | TRI | |
|---|---|---|
Market Cap | $46.49B | $43.89B |
Volume | 2,567,704 | 1,648,199 |
Sector | Health | Industrials |
52-Week High | $431.03 | $163.45 |
52-Week Low | $163.67 | $76.55 |
Typical Hold Time | 51 Days | 63 Days |
Enterprise Value | $53.84B | $46.51B |
Dividend Yield | 0.91% | 2.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 2.37% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $457.05 implying 18% upside. Revenue growth is robust, reaching $129.7 billion in 2025, though net income margin has compressed to 0.88%. Recent news includes a Barclays upgrade to a $515 target and upcoming Q3 earnings on November 6, 2026.
The stock offers potential from strong revenue expansion and positive analyst sentiment, but faces risks from margin pressure and regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes. The outlook hinges on earnings performance and Medicare Advantage plan changes affecting membership.
Thomson Reuters (TRI) trades at $101.55, up 2.29% on the day, with a bullish technical signal supported by moving averages. The company maintains strong profitability with 75.7% gross margins and 21.22% net income margins, though Q4 2025 earnings slightly missed expectations. Recent strategic moves include divesting its printing unit to focus on technology offerings and launching a proprietary AI model, positioning for future growth in legal tech and content services.
Outlook remains positive with analyst consensus price target of $133.25 (31% upside) and 52% buy ratings. Key risks include cybersecurity incidents and execution of AI strategy. Revenue growth is projected at 4% for 2026, supported by recurring revenue streams and organic growth in core businesses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Thomson Reuters Corp
Thomson Reuters is the result of the $17.6 billion megamerger of Canada's Thomson and the United Kingdom's Reuters Group in 2008 and the 2018 carve-out of its finance and risk business, Refinitiv, in which it holds a 45% stake. In 2019, the company agreed to exchange its 45% stake in Refinitiv for a 15% stake in LSE, which closed in early 2021. Since the divestiture, the company is more concentrated on selling its flagship legal data and software, Westlaw, and its tax accounting software, Onesource. Reuters sees roughly 80% of revenue and 70% of expenses attributed to the United States, while the remainder (largely through the global print and Reuters News segments) is distributed across Latin America, Europe, the Middle East, Africa, and Asia-Pacific.
Read more on TRI →
